XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Sales        
Total sales $ 2,330 $ 2,348 $ 8,346 $ 5,390
Cost of sales        
Total cost of sales 1,206 1,660 4,623 4,783
Gross margin 1,124 688 3,723 607
Operating Expenses:        
Research and development 5,739 7,338 16,531 22,937
General and administrative 4,615 3,198 16,103 26,570
Sales and marketing 2,529 3,434 7,575 11,345
Total operating expenses 12,883 13,970 40,209 60,852
Loss from operations (11,759) (13,282) (36,486) (60,245)
Interest income 1,021 170 2,920 203
Other income (expense), net (19) (59) 12 (63)
Loss before provision for income taxes (10,757) (13,171) (33,554) (60,105)
Provision for income taxes 0 0 0 0
Net loss and comprehensive loss $ (10,757) $ (13,171) $ (33,554) $ (60,105)
Earnings Per Share, Basic $ (0.15) $ (0.19) $ (0.47) $ (0.85)
Earnings Per Share, Diluted $ (0.15) $ (0.19) $ (0.47) $ (0.85)
Denominator for Basic EPS - Weighted-average common stock 71,464,315 70,509,639 71,178,769 70,398,103
Denominator for Dilutive EPS - Weighted-average common stock 71,464,315 70,509,639 71,178,769 70,398,103
Device        
Sales        
Total sales $ 1,728 $ 1,945 $ 6,670 $ 4,305
Cost of sales        
Total cost of sales 835 1,215 3,321 3,511
Service        
Sales        
Total sales 602 403 1,676 1,085
Cost of sales        
Total cost of sales $ 371 $ 445 $ 1,302 $ 1,272